Clearmind Medicine (CMND) Common Equity (2021 - 2026)
Clearmind Medicine (CMND) posted Common Equity of $11.49 million for fiscal Q2 2026 (quarter ended Apr 30, 2026), up 399.3% from $2.3 million a year earlier and up 39.5% from the prior quarter.
Powered by 
Analysis
Clearmind Medicine (CMND) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2024 (ended Oct 31, 2024), Clearmind Medicine's Common Equity came in at $3.11 million, up 216.0% from FY2023.
- Annual Common Equity shows a four-year compound annual growth rate of 90.1% (FY2020 to FY2024).
- In prior fiscal years, Clearmind Medicine's Common Equity was $983,472 in FY2023, -$1.11 million in FY2022, $3.52 million in FY2021 and $237,740 in FY2020.
- The fiscal Q2 2026 figure stands as the highest quarterly Common Equity in data going back to fiscal Q4 2021.
- On a year-over-year basis, Common Equity increased in four of the last seven quarters, with growth averaging 95.1%.
- The strongest year-over-year quarter for Common Equity in the past five years was fiscal Q2 2026, with growth of 399.3%; the weakest was fiscal Q3 2025, with a decline of 69.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Clearmind Medicine | 9,526.05 | -39.89 Mn | - | 12.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 12.95 Mn |
| Apr 30, 2026 | 11.49 Mn |
| Jan 31, 2026 | 8.24 Mn |
| Oct 31, 2025 | 1.19 Mn |
| Jul 31, 2025 | 1.07 Mn |
| Apr 30, 2025 | 2.30 Mn |
| Jan 31, 2025 | 2.85 Mn |
| Oct 31, 2024 | 3.11 Mn |
| Jul 31, 2024 | 3.47 Mn |
| Apr 30, 2024 | 4.65 Mn |
| Jan 31, 2024 | 5.04 Mn |
| Oct 31, 2023 | 983,472.00 |
| Jul 31, 2023 | 2.78 Mn |
| Apr 30, 2023 | 3.27 Mn |
| Jan 31, 2023 | 3.84 Mn |
| Oct 31, 2022 | -1.11 Mn |
| Jul 31, 2022 | -8.59 Mn |
| Jan 31, 2022 | 2.40 Mn |
| Oct 31, 2021 | 3.89 Mn |
API Access
Clearmind Medicine Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();